Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation
Background: Levodopa-carbidopa intestinal gel (LCIG) is effective in the treatment of advanced Parkinson’s disease (PD). However, the patients’ profile that might benefit from treatment with LCIG has not been characterized. Objective: This retrospective study explored the influence of disease durati...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publishing
2019-02-01
|
| Serie: | Journal of Parkinson’s Disease |
| Accesso online: | https://doi.org/10.3233/JPD-181324 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|